Healthcare & Life Science Talking Points | 29/03/2018

In todays talking points: Reforms aim to make healthcare more accessible and affordable in China; China inaugurates National Health Commission; Melbourne IVF clinic develops smart TV app to consult Chinese fertility patients


Reforms aim to make healthcare more accessible and affordable in China

A series of sweeping supply chain reforms are taking place in China’s healthcare industry, aiming to make healthcare more accessible and affordable to the 1.4 billion potential customers in China. Reforms include changing the health management structure to provide medical insurance for all, and changing how medical materials and equipment are supplied to rural areas. These reforms combined with the fast-paced development of the medical science field in China are making a major contribution towards the goal of a healthy China.

Read more on CGTN America

China inaugurates National Health Commission

On Tuesday 27th March China officially inaugurated the new National Health Commission – part of a big institutional reshuffle stemming from the Party Congress earlier this month. The new National Health Commssion was created to offer comprehensive health services to all people more efficiently and to improve the health conditions of all Chinese people through enhancing disease prevention and health education instead of illness treatment.

Read more on Xinhua

Melbourne IVF Clinic develops smart TV app to consult Chinese Fertility Patients

Monash IVF fertility clinic in Melbourne has developed a new app in collaboration with “BabySmart” platform that allows couples in China to have face-to-face consultations with Australian clinicians. Demand for IVF in China has soared in the past few years, and the Melbourne clinic has begun offering services to the Chinese market after partnering with the company AC International Medical Tourism – which targets the Chinese market. The Australian Healthcare market is considered one of the best in the world, and this partnership will allow greater access to better medicine for the Chinese market, while boosting the Australian domestic healthcare market.

Read more on ABC